Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-3925

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-3925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Oxcarbazepine 600mg 70518 3925 01)

Mm2 (Oxcarbazepine 600mg 70518 3925 01)
This text provides information about a medication called OXcarbazepine. It is a tablet with a dosage of 600 mg. The quantity available is 1 tablet. The medication is available for prescription use only. The NDC number for this medication is 70518-3925-01. The manufacturer is Camber Pharma, Inc, located in Piscataway, NJ 08854. The text advises keeping the medication out of the reach of children. Directions for use can be found in the package insert. It should be stored at a temperature between 20-25°C (58-77°F), with excursions permitted to 15.30°C (59-86°F) [as per USP]. The text also mentions that it has been repackaged by RemedyRepack nc., located in Indiana, PA 15701, with a contact number of 724.465.8762.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description for a medication called Oxcarbazepine in tablet form. The tablets are 600 mg each, and there are 100 tablets in each package. The medication is available only with a prescription. The National Drug Code (NDC) for this medication is 70518-3925-00. The expiration date and lot number are not available. The source NDC is 31722-0025-01 and the manufacturer is Camber Pharma, Inc, located in Piscataway, NJ 08854. It is important to keep this medication out of the reach of children. The directions for use are mentioned in the package insert, and the recommended storage temperature is between 20-25°C (58-77°F), with excursions permitted between 15.30°C (59-86°F) as per USP guidelines. The medication has been repackaged by RemedyRepack Inc., located in Indiana, PA 15701, and their contact number is 724.465.8762.*
FDA Label Image

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)
The text provides the results of a log-rank test with a p-value of 0.0001. It also includes a table with data labeled as "Day2," "Time on trial from Day 2 (days)," and "Day 11." There is a mention of a treatment group called "Oxcarbarspine."*
FDA Label Image

Oxcarbazepinetabfig2 (Oxcarbazepinetabfig2)

FDA Label Image

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)
The log-rank test was conducted and resulted in a p-value of 0.0001. The data provided shows the values for Time to Exit (in days) in the Treatment Group, ranging from 10 to 130. The treatment groups are labeled as HIGH and LOW.*
FDA Label Image

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)
This text provides the results of a statistical test called the log-rank test. The p-value obtained from the test is 0.0001, indicating a statistically significant result. The text also mentions a chart or graph displaying data related to "S RARANLARls REARRuANS) RRsysiaay tREa uatantnns a]", with time in days on the x-axis. The treatment groups mentioned in the text are labeled "HIGH" and "LOW".*
FDA Label Image

Oxcarbazepinetabstruct (Oxcarbazepinetabstruct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.